Response of myelodysplastic syndrome marrow progenitor cells to stimulation with cytokine combinations in a stroma‐free long‐term culture system
Davide Soligo, Lorenza Romitti(Istituti Clinici di Perfezionamento), Patrizia Bossolasco(Pirelli (Italy)), S. Campiglio(Ospedale Maggiore), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), F. Servida(Pirelli (Italy))
Cited by 18
Related Papers
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373
Angiogenesis in myelodysplastic syndromes
|British Journal of Cancer|1999|272
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
|Leukemia|2018|250